Our top pick for
IsoPlexis Corp is a medical devices business based in the US. IsoPlexis shares (ISO) are listed on the NASDAQ and all prices are listed in US Dollars. IsoPlexis employs 232 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$8.35|
|52-week range||$4.77 - $16.95|
|50-day moving average||$10.44|
|200-day moving average||$10.76|
|Wall St. target price||$20.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-33.35|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-01-12)||1.71%|
|1 month (2021-12-17)||62.77%|
|3 months (2021-10-19)||-24.09%|
|6 months (2021-07-15)||N/A|
|1 year (2021-01-15)||N/A|
|2 years (2020-01-15)||N/A|
|3 years (2019-01-15)||N/A|
|5 years (2017-01-15)||N/A|
|Revenue TTM||$15.1 million|
|Gross profit TTM||$5.4 million|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||$325.3 million|
TTM: trailing 12 months
We're not expecting IsoPlexis to pay a dividend over the next 12 months.
You may also wish to consider:
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States and Europe. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations without the need for highly specialized informatics professionals, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut. .
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.